The BMJ reports this week that the FDA has launched a ‘BadAd’ campaign to make it easier for doctors to report inaccurate or incomplete advertising or information from drug company representatives. The idea came from former drug reps now working for the FDA. This is a challenge to pharma who sincerely want to be seen as partners in healthcare, motivated by improving health not just the bottom line. To be given the respect that they desire, not only should their response be to welcome this move but to do everything they can to support it. They have nothing to lose other than wayward reps.
Like this:
Like Loading...
Related
About Julia Manning
Julia is a social pioneer, writer and campaigner. She studied visual science at City University and became a member of the College of Optometrists in 1991, later specialising in visual impairment and diabetes. During her career in optometry, she lectured at City University, was a visiting clinician at the Royal Free Hospital and worked with Primary Care Trusts. She ran a domiciliary practice across south London and was a Director of the UK Institute of Optometry.
Julia formed 20/20Health in 2006. Becoming an expert in digital health solutions, she led on the NHS–USA Veterans’ Health Digital Health Exchange Programme and was co-founder of the Health Tech and You Awards with Axa PPP and the Design Museum. Her research interests are now in harnessing digital to improve personal health, and she is a PhD candidate in Human Computer Interaction (HCI) at UCL. She is also dedicated to creating a sustainable Whole School Wellbeing Community model for schools that builds relationships, discovers assets and develops life skills. She is a member of the Royal Society of Medicine’s Digital Health Council.
Julia has shared 2020health's research widely in the media (BBC News, ITV, Channel 5 News, BBC 1′s The Big Questions & Victoria Derbyshire, BBC Radio 4 Today, PM and Woman's Hour, LBC) and has taken part in debates and contributed to BBC’s Newsnight, Panorama, You and Yours and ITV’s The Week.
The BMJ reports this week that the FDA has launched a ‘BadAd’ campaign to make it easier for doctors to report inaccurate or incomplete advertising or information from drug company representatives. The idea came from former drug reps now working for the FDA. This is a challenge to pharma who sincerely want to be seen as partners in healthcare, motivated by improving health not just the bottom line. To be given the respect that they desire, not only should their response be to welcome this move but to do everything they can to support it. They have nothing to lose other than wayward reps.
2020health's Blog 
You must be logged in to post a comment.